🌶️Pepperpedia
Community(soon)

Urea Cycle Metabolism

From Pepperpedia, the free peptide encyclopedia
Urea Cycle Metabolism
Properties
CategoryMechanisms
Also known asurea cycle, Krebs-Henseleit cycle, ornithine cycle
Last updated2026-04-14
Reading time4 min read
Tags
mechanismmetabolism

Overview

The urea cycle is a five-step hepatic pathway that disposes of ammonia — a highly toxic product of amino acid catabolism — by converting it to urea for renal excretion. Described by Hans Krebs and Kurt Henseleit in 1932, it was one of the earliest metabolic cycles identified. The cycle operates exclusively in hepatocytes (though partial reactions exist in some other tissues), spans the mitochondrial matrix and cytoplasm, and produces roughly 20-30 grams of urea per day in adults on a typical Western diet.

Nitrogen enters the cycle from two sources: free ammonia (mostly produced by glutamate dehydrogenase in hepatic mitochondria) and the amino group of aspartate (derived from glutamate via transamination). Each turn of the cycle incorporates one nitrogen from each source into urea, consuming three ATP equivalents. The cycle intermediates (ornithine, citrulline, arginine) are shuttled between mitochondrion and cytoplasm with regenerated ornithine ready for the next turn.

Urea cycle disorders — inherited enzyme deficiencies — cause hyperammonemia with neurologic consequences ranging from subtle cognitive effects to coma and death. Ornithine transcarbamylase (OTC) deficiency, the most common urea cycle disorder, is X-linked. Treatments include protein restriction, nitrogen-scavenging drugs (sodium phenylbutyrate, sodium benzoate, glycerol phenylbutyrate), dialysis in acute presentations, and liver transplantation for severe cases.

Mechanism / Process

  1. Carbamoyl phosphate synthesis. In the mitochondrial matrix, carbamoyl phosphate synthetase I (CPS1) condenses ammonia, bicarbonate, and two ATP into carbamoyl phosphate. This is the first and rate-limiting step, requiring N-acetylglutamate as an obligate allosteric activator.

  2. Citrulline synthesis. Ornithine transcarbamylase (OTC) transfers the carbamoyl group to ornithine, forming citrulline. Citrulline is exported from the mitochondrion by the ORNT1 transporter.

  3. Argininosuccinate synthesis. In the cytoplasm, argininosuccinate synthetase (ASS1) condenses citrulline with aspartate to form argininosuccinate, consuming ATP (to AMP plus pyrophosphate, equivalent to two ATP).

  4. Arginine and fumarate production. Argininosuccinate lyase (ASL) cleaves argininosuccinate into arginine and fumarate. The fumarate enters the TCA cycle, linking the urea cycle to energy metabolism.

  5. Urea production. Arginase (ARG1) hydrolyzes arginine to urea and ornithine. Urea is released into blood for renal excretion; ornithine is transported back into the mitochondrion (via ORNT1) to restart the cycle.

  6. Ammonia sources. Free ammonia arises from glutamate dehydrogenase (GDH) acting on glutamate, and from glutamine hydrolysis by glutaminase. These reactions concentrate nitrogen in the mitochondria for CPS1.

  7. Second nitrogen source. Aspartate carries the second urea nitrogen; it is generated by transamination of oxaloacetate with glutamate (catalyzed by aspartate aminotransferase).

  8. Regulation. N-acetylglutamate synthase (NAGS) produces N-acetylglutamate, whose concentration regulates CPS1 activity. Arginine activates NAGS, linking urea cycle capacity to protein load. Chronic high-protein diet upregulates cycle enzyme expression.

Key Players / Molecular Components

  • CPS1. Mitochondrial rate-limiting enzyme.
  • NAGS. Produces obligate allosteric activator.
  • OTC. Mitochondrial; most common urea cycle disorder.
  • ASS1, ASL, ARG1. Cytoplasmic enzymes.
  • ORNT1 (SLC25A15), Citrin (SLC25A13). Mitochondrial transporters.
  • GDH, glutaminase, AST. Nitrogen-mobilizing enzymes.

Clinical Relevance / Therapeutic Targeting

Urea cycle disorders cause hyperammonemia with brain edema, lethargy, vomiting, seizures, coma, and death if untreated. Presentation ranges from neonatal catastrophe to late-onset episodic hyperammonemia. Management uses low-protein diet, essential amino acid supplementation, and nitrogen scavengers (sodium phenylbutyrate, glycerol phenylbutyrate, sodium benzoate) that conjugate amino acids into urea-like compounds for urinary excretion. Arginine or citrulline supplementation restores downstream substrate. Liver transplantation cures the enzyme deficiency. Acquired hyperammonemia occurs in liver failure, portosystemic shunts, and valproate toxicity. Measuring ammonia is critical in altered mental status, especially in children.

Peptides That Target This Pathway

  • Arginine vasopressin — physiologically linked but does not directly alter urea cycle flux.
  • Glucagon — induces urea cycle enzymes during protein-rich feeding or fasting.
  • Insulin — suppresses hepatic protein breakdown, reducing nitrogen load.
  • Growth hormone — influences nitrogen balance and ureagenesis.
  • CCK — regulates hepatic response to dietary protein.

Related entries

  • Gluconeogenesis— Gluconeogenesis is the metabolic pathway by which the liver and kidneys synthesize new glucose from non-carbohydrate precursors, maintaining blood sugar during fasting and prolonged exercise.
  • Amino Acid Catabolism— The pathways that dispose of dietary or mobilized amino acids by separating nitrogen for the urea cycle and channeling carbon skeletons into energy metabolism.
  • Gluconeogenesis— The hepatic and renal synthesis of glucose from non-carbohydrate precursors such as lactate, amino acids, and glycerol during fasting and exercise.
  • Mitochondrial Function— Mitochondrial function encompasses the energy-producing, signaling, and quality-control processes within mitochondria, including oxidative phosphorylation, ROS management, apoptosis regulation, and the emerging biology of mitochondrial-derived peptides.
  • Nucleotide Synthesis— The de novo and salvage pathways that produce the purine and pyrimidine nucleotides required for DNA, RNA, cofactors, and energy metabolism.